Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activity.
Levy GA, Adamson G, Phillips MJ, Scrocchi LA, Fung L, Biessels P, Ng NF, Ghanekar A, Rowe A, Ma MX, Levy A, Koscik C, He W, Gorczynski R, Brookes S, Woods C, McGilvray ID, Bell D.
Levy GA, et al. Among authors: mcgilvray id.
Hepatology. 2006 Mar;43(3):581-91. doi: 10.1002/hep.21072.
Hepatology. 2006.
PMID: 16496340
Free PMC article.